RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제
      • 좁혀본 항목 보기순서

        • 원문유무
        • 원문제공처
        • 등재정보
        • 학술지명
        • 주제분류
        • 발행연도
        • 작성언어
        • 저자
          펼치기

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        Mechanisms and kinetics of zinc and iron separation enhanced by calcified carbothermal reduction for electric arc furnace dust

        Jiayong Qiu,Shui Yu,Jiugang Shao,Kaiqi Zhu,Dianchun Ju,Chunyu Chen,Dexing Qi,Fei Wang,Ni Bai,Rui Mao,Xiaoming Wang 한국화학공학회 2023 Korean Journal of Chemical Engineering Vol.40 No.4

        A high basicity charge prepared with electric arc furnace dust (EAFD), carbonaceous reducing agent and CaO is proposed. The mechanisms of enhancing separation of zinc and iron by calcified carbothermic reduction of the high basicity charge were analyzed by combining thermal analysis kinetics and experiment. The influences of roasting temperature, carbon ratio (nc/no, molar ratio of carbon in graphitic carbon powder to oxygen in EAFD), and CaO dosage on phase transition and dezincification ratio in EAFD were investigated. The results show that the intermediates Ca2Fe2O5 and Fe0.85−xZnxO can be produced from the zinc-iron separation of zinc ferrate during the process of calcified carbothermic reduction of EAFD. Addition of CaO and C results in the following transition pathways: ZnFe2O4+ CaO→Ca2Fe2O5+ZnO→Ca2Fe2O5+Zn(g)→CaO+Fe; Fe0.85−xZnxO+CaO→Ca2Fe2O5+FeO+ZnO→CaO+Fe+Zn(g). In the range of nc/no of 0.4–1.2 and roasting temperature of 1,000–1,100 °C, the addition of CaO can promote reduction and dezincification. Based on the Kissinger-Akahira-Sunose (KAS) and Coats-Redfern methods, the kinetic results show that the calcified carbothermic reduction process can be divided into three stages: initial stage (α=0–0.3), middle stage (α=0.3–0.45), and final stage (α=0.45–1.0). The average activation energy of the initial stage is 305.01 kJ·mol−1, and the reaction mechanism is one-dimensional diffusion. The average activation energy is 315.67 kJ·mol−1 for the middle stage and 288.22 kJ·mol−1 for the final stage. The chemical reaction equation is found to be the most suitable mechanism in the medium and final stages. It is also found that the addition of CaO can reduce the average activation energy by about 32 kJ·mol−1 and shorten the intermediate stage of the reaction.

      • CEA, AFP, CA125, CA153 and CA199 in Malignant Pleural Effusions Predict the Cause

        Wang, Xin-Feng,Wu, Yan-Hua,Wang, Mao-Shui,Wang, Yun-Shan Asian Pacific Journal of Cancer Prevention 2014 Asian Pacific journal of cancer prevention Vol.15 No.1

        Determination of the cause of malignant pleural effusions is important for treatment and management, especially in cases of unknown primaries. There are limited biomarkers available for prediction of the cause of malignant pleural effusion in clinical practice. Hence, we evaluated pleural levels of five tumor biomarkers (CEA, AFP, CA125, CA153 and CA199) in predicting the cause of malignant pleural effusion in a retrospective study. Kruskal-Wallis or Mann-Whitney U tests were carried out to compare levels of tumor markers in pleural effusion among different forms of neoplasia - lung squamous cell carcinoma, adenocarcinoma, or small cell carcinoma, mesothelioma, breast cancer, lymphoma/leukemia and miscellaneous. Receiver operator characteristic analysis was performed to evaluate sensitivity and specificity of biomarkers. The Kruskal-Wallis test showed significant differences in levels of pleural effusion CEA (P<0.01), AFP (P<0.01), CA153 (P<0.01) and CA199 (P<0.01), but not CA125 (P>0.05), among the seven groups. Receiver operator characteristic analysis showed that, compared with other four tumor markers, CA153 was the best biomarker in diagnosing malignant pleural effusions of lung adenocarcinoma (area under curve (AUC): 0.838 (95%confidence interval: 0.787, 0.888); cut-off value: 10.2U/ml; sensitivity: 73.2% (64.4-80.8)%, specificity: 85.2% (77.8-90.8)%), lung squamous cell carcinoma (AUC: 0.716 (0.652, 0.780); cut-off value: 14.2U/ml; sensitivity: 57.6% (50.7-64.3)%, specificity: 91.2% (76.3-98.0)%), and small-cell lung cancer (AUC: 0.812 (0.740, 0.884); cut-off value: 9.7U/ml; sensitivity: 61.5% (55.0-67.8)%, specificity: 94.1% (71.2-99.0)%); CEA was the best biomarker in diagnosing MPEs of mesothelioma (AUC: 0.726 (0.593, 0.858); cut-off value: 1.43ng/ml; sensitivity: 83.7% (78.3-88.2)%, specificity: 61.1% (35.8-82.6)%) and lymphoma/leukemia (AUC: 0.923 (0.872, 0.974); cut-off value: 1.71ng/ml; sensitivity: 82.8% (77.4-87.3)%, specificity: 92.3% (63.9-98.7)%). Thus CA153 and CEA appear to be good biomarkers in diagnosing different causes of malignant pleural effusion. Our findings implied that the two tumor markers may improve the diagnosis and treatment for effusions of unknown primaries.

      • KCI등재

        Protection Against Helicobacter pylori Infection by a Trivalent Fusion Vaccine Based on a Fragment of Urease B-UreB414

        Li Wang,Xiao-Fei Liu,Shi Yun,Xiao-Peng Yuan,Xu-Hu Mao,Chao Wu,Wei-Jun Zhang,Kai-Yun Liu,Gang Guo,Dong-Shui Lu,Wen-De Tong,Ai-Dong Wen,Quan-Ming Zou 한국미생물학회 2010 The journal of microbiology Vol.48 No.2

        A multivalent fusion vaccine is a promising option for protection against Helicobacter pylori infection. In this study, UreB414 was identified as an antigenic fragment of urease B subunit (UreB) and it induced an antibody inhibiting urease activity. Immunization with UreB414 partially protected mice from H. pylori infection. Furthermore, a trivalent fusion vaccine was constructed by genetically linking heat shock protein A (HspA), H. pylori adhesin A (HpaA), and UreB414, resulting in recombinant HspA-HpaA-UreB414 (rHHU). Its protective effect against H. pylori infection was tested in BALB/c mice. Oral administration of rHHU significantly protected mice from H. pylori infection, which was associated with H. pylori-specific antibody production and Th1/Th2-type immune responses. The results show that a trivalent fusion vaccine efficiently combats H. pylori infection, and that an antigenic fragment of the protein can be used instead of the whole protein to construct a multivalent vaccine.

      • Diagnostic Value of Superoxide Dismutase in Tuberculous and Malignant Pleural Effusions

        Wang, Xin-Feng,Wu, Yan-Hua,Jiao, Jin,Guan, Cui-Ping,Yang, Xiao-Guang,Wang, Mao-Shui Asian Pacific Journal of Cancer Prevention 2013 Asian Pacific journal of cancer prevention Vol.14 No.2

        The aim of this study was to investigate the diagnostic value of superoxide dismutase (SOD) in tuberculous pleural effusions (TPEs) and malignant pleural effusions (MPEs). Pleural effusion (PE) samples from 100 patients were classified on the basis of diagnosis as TPE (n=57) and MPE (n=43). The activity of SOD was determined by pyrolgallol assay. A significant difference was observed in SOD activity (P<0.01) between TPE and MPE, levels of being significantly higher in TPE compared to MPE. With a threshold value of 41 U/L, the area under the ROC curve was 0.653, SOD had a sensitivity of 61.4% and a specificity of 61.0% for differential diagnosis. Thus, SOD activity in PE was not a good biomarker in differentiating TPE and MPE. To the best of our knowledge, five SOD isoforms may be present in PE. Identification of which SOD contributes to the difference of SOD level between TPE and MPE is very important for illustrating mechanisms and improving the differential diagnostic value.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼